Nestlé Health Science tackles age-related cellular decline with Celltrient launch

Related Articles

FormattedPicture

BUSINESS NEWS

Nestlé could be potentially divesting its peanut allergy treatment Palforzia following slower than expected adoption by patients and healthcare professionals.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé’s Nutrition & Health Science marked a CHF 7.7 billion (US$8 billion) sales growth in the first half of the year, the company’s latest... Read More

FormattedPicture

BUSINESS NEWS

Nestlé Health Science is set to acquire The Better Health Company (TBHC), as part of its goals to grow global market share while spurring innovation across the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

New research is suggesting a link between walnut consumption and lower cancer risk. The sub-study of the Walnuts and Healthy Aging (WAHA) trial looks at the interplay of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé Health Science is set to acquire Brazil-based Puravida, expanding its presence across the vitamins, minerals, herbals and supplements segment.

trans